ONO-5334

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameONO-5334
Drug Alias NameONO-5334
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoporosisBone Diseases, Metabolic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoporosisBone Diseases, Metabolic

Other Information

ATC CodeN/A
Related LinksN/A